sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Neuropathic Pain: Epidemiology Forecasting Intelligence

Neuropathic Pain: Epidemiology Forecasting Intelligence

Home / Categories / Healthcare
Neuropathic Pain: Epidemiology Forecasting Intelligence
Neuropathic Pain: Epidemiology Forecasting Intelligence
Report Code
RO1/114/1036

Publish Date
01/Mar/2019

Pages
50-70
PRICE
$ 2500/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 6000/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
1. Report Introduction
2. Neuropathic Pain Epidemiology Overview at a Glance
3. Market Share Distribution of Neuropathic Pain
4. Disease Background and Overview: Neuropathic Pain
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Neuropathic Pain Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Neuropathic Pain by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Neuropathic Pain
7.3. Sub-Type Specific cases of Neuropathic Pain*
7.4. Sex- Specific Cases of Neuropathic Pain*
7.5. Diagnosed Cases of Neuropathic Pain
7.6. Treated Cases of Neuropathic Pain
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Neuropathic Pain
8.1.3. Sub-Type Specific cases of Neuropathic Pain*
8.1.4. Sex- Specific Cases of Neuropathic Pain*
8.1.5. Diagnosed Cases of Neuropathic Pain
8.1.6. Treated Cases of Neuropathic Pain
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Neuropathic Pain
8.2.3. Sub-Type Specific cases of Neuropathic Pain*
8.2.4. Sex- Specific Cases of Neuropathic Pain*
8.2.5. Diagnosed Cases of Neuropathic Pain
8.2.6. Treated Cases of Neuropathic Pain
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Neuropathic Pain
8.3.3. Sub-Type Specific cases of Neuropathic Pain*
8.3.4. Sex- Specific Cases of Neuropathic Pain*
8.3.5. Diagnosed Cases of Neuropathic Pain
8.3.6. Treated Cases of Neuropathic Pain
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Neuropathic Pain
8.4.3. Sub-Type Specific cases of Neuropathic Pain*
8.4.4. Sex- Specific Cases of Neuropathic Pain*
8.4.5. Diagnosed Cases of Neuropathic Pain
8.4.6. Treated Cases of Neuropathic Pain
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Neuropathic Pain
8.5.3. Sub-Type Specific cases of Neuropathic Pain*
8.5.4. Sex- Specific Cases of Neuropathic Pain*
8.5.5. Diagnosed Cases of Neuropathic Pain
8.5.6. Treated Cases of Neuropathic Pain
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Neuropathic Pain
9.3. Sub-Type Specific cases of Neuropathic Pain*
9.4. Sex- Specific Cases of Neuropathic Pain*
9.5. Diagnosed Cases of Neuropathic Pain
9.6. Treated Cases of Neuropathic Pain
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com